Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merck

79.31
+0.38000.48%
Volume:8.28M
Turnover:656.65M
Market Cap:199.15B
PE:11.53
High:80.41
Open:79.61
Low:78.67
Close:78.93
Loading ...

BRIEF-Merck Animal Health And State Of Kansas Announce $895 Million Investment In Manufacturing And Research & Development Facilities In De Soto

Reuters
·
08 May

Merck Animal Health announces $895 million investment in Kansas

Reuters
·
08 May

Merck & Co Inc - Project to Create 2,500 Construction Jobs, 200 Full-Time Roles

THOMSON REUTERS
·
08 May

Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto

THOMSON REUTERS
·
08 May

Merck & Co Inc - Commercial Manufacturing Expected to Begin in 2030

THOMSON REUTERS
·
08 May

BUZZ-US drugmakers fall on report of Trump plan to lower drug prices

Reuters
·
08 May

Gilead boosts planned US investments by $11 billion amid tariff threat

Reuters
·
08 May

National Legal and Policy Center Urges Merck Shareholders to Vote for Shareholder Proposal to Revisit Dei Goals in Executive Pay Incentives - Filing

THOMSON REUTERS
·
07 May

Stock Track | Merck Plunges 5% as Trump's Tariff Threats and FDA's Surprise Inspection Plans Rattle Pharma Stocks

Stock Track
·
07 May

FDA Plans to Increase Surprise Inspections at Overseas Manufacturing Sites

MT Newswires Live
·
07 May

BUZZ-Drugmakers fall as Trump signals announcement on medicine costs

Reuters
·
06 May

US STOCKS-Wall Street declines after Trump's latest tariff threats

Reuters
·
06 May

Pharma Stocks Sink as Trump Sets Pharma Tariffs Deadline. Moderna Down 5%; Merck, Eli Lilly Down over 2%

Dow Jones
·
06 May

Dow's 300-Point Drop Led By Losses In Shares Of Merck, NVIDIA Corp.

Dow Jones
·
06 May

Top Midday Gainers

MT Newswires Live
·
06 May

Immutep Cancer Treatment Shows High Survival Rate

Dow Jones
·
05 May

Immutep Reports 'Excellent' Median Overall Survival in Efti-Keytruda Combo Trial; Shares Rise

MT Newswires Live
·
05 May

Immutep’s Efti in Combination with KEYTRUDA® (pembrolizumab) Drives Strong Overall Survival in Head and Neck Cancer with CPS <1

GlobeNewswire
·
05 May

Insider Moves: Procter & Gamble, Strategy, Merck, Bristol-Myers, AGNC

TIPRANKS
·
03 May

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?

Motley Fool
·
03 May